1. Home
  2. DGHI vs CTOR Comparison

DGHI vs CTOR Comparison

Compare DGHI & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGHI
  • CTOR
  • Stock Information
  • Founded
  • DGHI 2017
  • CTOR 2021
  • Country
  • DGHI United States
  • CTOR United States
  • Employees
  • DGHI N/A
  • CTOR N/A
  • Industry
  • DGHI Finance: Consumer Services
  • CTOR
  • Sector
  • DGHI Finance
  • CTOR
  • Exchange
  • DGHI Nasdaq
  • CTOR NYSE
  • Market Cap
  • DGHI 90.1M
  • CTOR 89.9M
  • IPO Year
  • DGHI N/A
  • CTOR N/A
  • Fundamental
  • Price
  • DGHI $2.63
  • CTOR $1.25
  • Analyst Decision
  • DGHI Strong Buy
  • CTOR Strong Buy
  • Analyst Count
  • DGHI 1
  • CTOR 2
  • Target Price
  • DGHI $2.50
  • CTOR $4.50
  • AVG Volume (30 Days)
  • DGHI 1.0M
  • CTOR 68.9K
  • Earning Date
  • DGHI 04-02-2025
  • CTOR 02-14-2025
  • Dividend Yield
  • DGHI N/A
  • CTOR N/A
  • EPS Growth
  • DGHI N/A
  • CTOR N/A
  • EPS
  • DGHI N/A
  • CTOR N/A
  • Revenue
  • DGHI $42,146,057.00
  • CTOR N/A
  • Revenue This Year
  • DGHI N/A
  • CTOR N/A
  • Revenue Next Year
  • DGHI N/A
  • CTOR N/A
  • P/E Ratio
  • DGHI N/A
  • CTOR N/A
  • Revenue Growth
  • DGHI 100.56
  • CTOR N/A
  • 52 Week Low
  • DGHI $0.84
  • CTOR $0.85
  • 52 Week High
  • DGHI $3.77
  • CTOR $49.00
  • Technical
  • Relative Strength Index (RSI)
  • DGHI 49.56
  • CTOR N/A
  • Support Level
  • DGHI $2.81
  • CTOR N/A
  • Resistance Level
  • DGHI $3.48
  • CTOR N/A
  • Average True Range (ATR)
  • DGHI 0.46
  • CTOR 0.00
  • MACD
  • DGHI -0.06
  • CTOR 0.00
  • Stochastic Oscillator
  • DGHI 10.24
  • CTOR 0.00

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: